Neos Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results
15 mars 2018 07h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, March 15, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Host Fourth Quarter and Year-End 2017 Financial Results Conference Call on March 15, 2017
08 mars 2018 07h30 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, March 08, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at the Cowen & Co. Annual Health Care Conference
05 mars 2018 08h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, March 05, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present Three Posters at the Upcoming American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting
10 janv. 2018 08h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Neos Therapeutics to Participate in Two December Conferences
28 nov. 2017 08h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Neos Therapeutics Reports Third Quarter 2017 Financial Results
08 nov. 2017 07h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
Neos Therapeutics to Present at the Stifel 2017 Healthcare Conference
07 nov. 2017 08h00 HE
|
Neos Therapeutics, Inc.
DALLAS/FORT WORTH, Texas, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Neos Therapeutics to Present Two Posters on Company’s ADHD Medications at the American Academy of Child & Adolescent Psychiatry Meeting
24 oct. 2017 16h21 HE
|
Neos Therapeutics, Inc.
DALLAS/FORT WORTH, Texas, Oct. 24, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS) today announced that it will present two posters at the 64th Annual Meeting of the American Academy...
Neos Therapeutics Announces Settlement with Actavis on Adzenys XR-ODT® Patent Litigation
18 oct. 2017 08h00 HE
|
Neos Therapeutics, Inc.
DALLAS and FORT WORTH, Texas, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative...
Neos Therapeutics Announces US Launch of Cotempla XR-ODT™ (methylphenidate) Extended-Release Orally Disintegrating Tablets for the Treatment of ADHD in Patients 6 to 17 Years Old
02 oct. 2017 08h00 HE
|
Neos Therapeutics, Inc
DALLAS/FORT WORTH, Texas, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...